OTCM
MDXL
Market cap1mUSD
Jun 01, Last price
0.01USD
Name
Medixall Group Inc
Chart & performance
P/E
—
P/S
3.72
EPS
—
Div yield, %
—
Shrs. gr., 5y
16.82%
Rev. gr., 5y
21.67%
Revenues
309k
+422.07%
Net income
-5m
L-33.19%
CFO
-1m
L-65.47%
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
MediXall Group, Inc., together with its subsidiaries, provides health solutions in the United States. The company offers Health Karma platform that provides bundle healthcare and well-being services to individuals, employer groups, organizations, associations, resellers, and third-party administrators. MediXall Group, Inc. was incorporated in 1998 and is based in Leesburg, Florida.
Key people
John Marino
Chief Executive Officer, Director · since 2013
Chief Financial Officer, Director · since 2016
Carl L. Larsen
Vice President · since 2016
Director · since 2018
Headquarters & legal address
C/O Incorp Services, Inc.
2360 Corporate Circle
Suite 400
Henderson, NV 89074-7722
US
2360 Corporate Circle
Suite 400
Henderson, NV 89074-7722
US
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|
| 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||
Revenues | ||||||||
Cost of revenue | ||||||||
Unusual Expense (Income) | ||||||||
NOPBT | ||||||||
NOPBT Margin | ||||||||
Operating Taxes | ||||||||
Tax Rate | ||||||||
NOPAT | ||||||||
Net income | ||||||||
Dividends | ||||||||
Dividend yield | ||||||||
Proceeds from repurchase of equity | ||||||||
BB yield | ||||||||
| Debt | ||||||||
Debt current | ||||||||
Long-term debt | ||||||||
Deferred revenue | ||||||||
Other long-term liabilities | ||||||||
Net debt | ||||||||
| Cash flow | ||||||||
Cash from operating activities | ||||||||
CAPEX | ||||||||
Cash from investing activities | ||||||||
Cash from financing activities | ||||||||
FCF | ||||||||
| Balance | ||||||||
Cash | ||||||||
Long term investments | ||||||||
Excess cash | ||||||||
Stockholders' equity | ||||||||
Invested Capital | ||||||||
ROIC | ||||||||
ROCE | ||||||||
| EV | ||||||||
Common stock shares outstanding | ||||||||
Price | ||||||||
Market cap | ||||||||
EV | ||||||||
EBITDA | ||||||||
EV/EBITDA | ||||||||
Interest | ||||||||
Interest/NOPBT | ||||||||